Crohn’s Disease Pipeline Insights, FDA Approvals, Drugs, Companies Report | DelveInsight
The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...
Pharmaceutical Technology11d
Etrasimod by Pfizer for Eosinophilic Esophagitis: Likelihood of Approval
GlobalData’s report assesses how Etrasimod’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks. Buy the report here. GlobalData tracks drug-specific phase ...
Alopecia Areata Market Set To Grow Substantially Through 2034, Delveinsight Projects
LAS VEGAS, NV, UNITED STATES, January 15, 2025 /EINPresswire / -- The Alopecia Areata market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period.
pharmaphorum1d
Pfizer’s Velsipity heading for NHS use in ulcerative colitis
The new guidance emerged on the same day that Velsipity (etrasimod) was approved by the Medicines ... It’s not the first drug in the class to become available for patients with moderate to ...
pharmaphorum1d
BMS eyes May FDA verdict for MS drug Zeposia in ulcerative colitis
Another potential rival – Arena Pharma’s oral S1P etrasimod – is in late-stage ... which picked up an FDA approval for this indication last month to add to its current use in rheumatoid ...
Medical News Today2d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
Forbes5d
Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug
Joel Stanley, former CEO of Charlotte’s Web, is part of a joint effort to achieve approval from the FDA for a novel treatment for the symptoms of autism spectrum disorder (ASD). Stanley is the ...
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
FDA Approves Nasal Spray for Depression
The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...
Indiatimes7d
FDA approves J&J’s nasal spray for severe depression as stand-alone treatment
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a significant advancement in depression treatment ...
FiercePharma13d
Government watchdog recommends tweaks to FDA accelerated approval program
A government watchdog examining the FDA’s accelerated approval pathway has released a 32-page report (PDF) that concludes the agency’s controversial endorsement of Biogen’s failed Alzheimer ...